C-I5HIPelage Pharmaceuticals
stem cell activation, topical small molecule, metabolic switch
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-I5HI
C-I5HIC-I5HIstem cell activation, topical small molecule, metabolic switch
0-100 chain-logic scale · 15 dimensions · scored on public evidence
In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients. *Host* https://www.linkedin.com/in/jennifersmithparker/, Director of Insights, BioSpace *Guests* https://www.linkedin.com/in/daniel-gil-165067aa/, CEO, Pelage Pharmaceuticals https://www.linkedin.com/in/francisco-ramirez-valle/, Senior Vice President, Immunology Discovery, Eli Lilly _Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations._
Kahlheit könnte bald der Vergangenheit angehören. Wissenschaftler der UCLA haben ein kleines Molekül namens PP405 entwickelt, das ruhende Haarfollikel-Stammzellen reaktivieren kann – und bereits nach einer Woche topischer Anwendung echtes, kräftiges Haarwachstum auslöst. Anders als herkömmliche Behandlungen wie Minoxidil oder Finasterid, die den Haarausfall meist nur verlangsamen oder lediglich bei einem Bruchteil der Betroffenen wirken, setzt PP405 an der eigentlichen Ursache an: Stammzellen der Haarfollikel, die in einen Ruhezustand gefallen sind, aber noch leben und grundsätzlich in der Lage wären, Haare zu bilden. Das Molekül hemmt ein bestimmtes Protein, das diese Stammzellen im Ruhezustand hält. Wird dieses Protein blockiert, „erwachen" die Follikel und nehmen ihren natürlichen Wachstumszyklus wieder auf. Phase-1-Studien am Menschen aus dem Jahr 2023 lieferten Ergebnisse, die die Forscher als „statistisch signifikant" bezeichneten – und die Behandlung schädigte dabei keine Folli
Baldness may soon be history. UCLA scientists have developed a small molecule called PP405 that can reactivate dormant hair follicle stem cells — triggering real, full-thickness hair regrowth in as little as one week of topical application. Unlike existing treatments such as minoxidil or finasteride, which mainly slow hair loss or work for only a fraction of users, PP405 targets the actual root cause: follicle stem cells that have gone dormant but remain alive and still capable of growing hair. The molecule works by inhibiting a specific protein that keeps those stem cells in a resting state. Once blocked, the follicles wake up and resume their natural growth cycle. Phase 1 human trials conducted in 2023 produced results the researchers described as "statistically significant" — and the treatment caused no follicle damage. The three scientists behind the breakthrough — William Lowry, Heather Christofk, and Michael Jung of UCLA — co-founded Pelage Pharmaceuticals to bring PP405 to mar
¿Sabías que la próxima gran solución para la caída del cabello no es solo un fármaco, sino un avance en medicina regenerativa? ¡Y tiene a algunos de los nombres más importantes de la ciencia y la tecnología detrás! 🚀 La historia de PP405 comienza en la UCLA, donde un brillante equipo de científicos (William Lowry, Heather Christofk y Michael Jung) descubrió cómo "despertar" las células madre del folículo piloso que habían dejado de funcionar. Para llevar este descubrimiento al mundo, fundaron Pelage Pharmaceuticals, una empresa dedicada a la medicina regenerativa. Su misión no es solo frenar la caída, sino revertirla restaurando la capacidad natural del cuerpo para generar cabello nuevo 🌱. Y aquí viene lo interesante: ¿quién vio el increíble potencial de esta ciencia? Nada menos que GV (Google Ventures), el brazo de capital de riesgo de Google, que ha invertido significativamente para impulsar los ensayos clínicos. Este no es solo un tratamiento más. Es la unión de la acade
UCLA scientists may have just revolutionized the future of hair loss treatment. In this episode, we explore the groundbreaking discovery of PP405, a small molecule that awakens dormant hair follicle stem cells — leading to full hair regrowth. Backed by promising early human trials, this innovation goes far beyond the limited results of traditional treatments. Discover how Professors William Lowry, Heather Christofk, and Michael Jung are reshaping the field of regenerative medicine — and how their spinout company, Pelage Pharmaceuticals, is racing toward FDA approval. 🎙️ Powered by AI 🔬 Based on verified science 💡 For anyone curious about the future of hair restoration 👉 Subscribe for more science-based podcast episodes driven by AI #HairLoss #UCLA #StemCells #HairRegrowth #Baldness #SciencePodcast #Biotech #PP405 #PelagePharmaceuticals
The "7-Day Hair Loss Cure": Separating Hype from Hope! Waking up to a pillow full of fallen hair or a receding hairline can be disheartening. So, when news breaks about a "magic cream" that promises to cure baldness in just one week, it sounds like a dream come true for millions! Social media is abuzz with claims that UCLA scientists have discovered a molecule, sometimes called PP405, that can bring back thick, strong hair in just 7 days when applied before sleep. This isn't entirely "fake news." UCLA researchers William Lowry, Heather Christofk, and Michael Jung, with their company Pelage Pharmaceuticals (backed by Google Ventures), are indeed doing groundbreaking work. They've identified molecules (CDK4/6 inhibitors) that can "wake up" dormant hair follicles by blocking a protein that keeps stem cells asleep. Their research has shown amazing, rapid results in animal studies, with significant hair growth in just a few weeks. However, here's the crucial twist: while incredibly promisi
The study is a two part study, designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK. Part 1 of the trial is the randomized controlled portion that will focus on safety and PK following 28 days of blinded treatment administration with either PP405 or vehicle control. Part 2 of the trial is an open-label extension that will validate the results of Part 1 with 3 months of treatment administration.
Episode 147 - Dan Gil - Pelage… - The BioHub - by Avetix - Apple Podcasts Search Home New Top Charts Search April 15 22 min Episode 147 - Dan Gil - Pelage Pharma The BioHub - by Avetix Play In todays episode we talk about Dan's career and the work Pelage are doing, leading innovation in the hair loss space. Episode Webpage Information Show The BioHub - by Avetix Frequency Updated Weekly Published April 15, 2026 at 10:08 AM UTC Length 22 min Rating Clean United States Español (México) العربية Русский 简体中文 Français (France) 한국어 Português (Brazil) Tiếng Việt 繁體中文 (台灣) Select a country or region A
Hair loss treatment company raises $120M, advances lead program PP405 | Pelage Pharmaceuticals posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to j … aFAN™, we’re thrilled to share that OnePass Medical has secured a Manufacturing Grant from the Israel Innovation Authority רשות החדשנות . This support is designed for transitioning from an innovation phase to large-scale production, and marks a crucial step in our journey. With it, we will establish an efficient, high-quality manufacturing process for the InstaFAN™, EUS multi-needle device. We’re grateful for the Israel Innovation Authority’s continued backing, and for our cl
Episode 147 - Dan Gil - Pelage Pharma - The BioHub - by Avetix | Podcast on Spotify
#timebestinventions | Pelage Pharmaceuticals | 20 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Po
UCLA’s Hair Growth Breakthroug... - Biology Career Insights - Apple Podcasts Search Home New Top Charts Search 16 July 2025 9 min UCLA’s Hair Growth Breakthrough: The Science Behind PP405 & the Future of Baldness Treatment Biology Career Insights Play UCLA scientists may have just revolutionized the future of hair loss treatment. In this episode, we explore the groundbreaking discovery of PP405, a small molecule that awakens dormant hair follicle stem cells — leading to full hair regrowth.Backed by promising early human trials, this innovation goes far beyond the limited results of traditi
Roots Start to Show for Hair Loss Startup Pelage With a Peek at First Clinical Data - MedCity News Twitter Facebook TikTok YouTube LinkedIn RSS Subscribe via email Newsletter Signup Send Tips Webinars eBooks Open navigation MedCity News Toggle Search Close navigation News Health Tech BioPharma Devices & Diagnostics Consumer / Employer Contributors MedCity Influencers Events Bullseye INVEST Digital Health Podcasts Research Newsletters Newsletter Signup Send Tips Webinars eBooks Twitter Facebook TikTok YouTube LinkedIn RSS Subscribe via email Search for: Search BioPharma, Pharma Roots Start … test in humans, the startup now has results showing that seven days of topical application of its experimental drug led to activation of hair follicle stem cells. Sponsored Post The Hidden Administrative Tasks Draining Small Practices Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences. By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health® Data from the … men. The main goal was to assess the safety of PP405. Both once and twice-daily application were tested. Minoxidil, the vasodilator that won an additional approval in 1988 for male pattern baldness and reached the market branded as Rogaine, is applied twice daily. The Pelage drug was well tolerated and no adverse effects were reported in the Phase 1 study. Gil said Michael Jung, a UCLA professor of chemistry and biochemistry and one of Pelage’s scientific co-founders, d … Phase 1 test showed once-daily use of PP405 had the same effect as twice-a-day application, said Gil, whose experience includes overseeing research and early clinical development at the former aesthetics giant Allergan. The Phase 2 study will evaluate once-daily application of the drug. In addition to old medications like minoxidil and finasteride that have won additional approvals for alopecia, other therapies have found their way into the hair loss market—some withou
Daniel Gil on Reactivating Hair Loss Treatment | Pelage Pharmaceuticals posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agr
Pelage Pharmaceuticals Raises $120M Series B for Hair Loss Treatment - Los Angeles Times News Home Page California Election 2024 Housing & Homelessness Politics Science & Medicine World & Nation Business Artificial Intelligence Autos Jobs, Labor & Workplace Real Estate Technology and the Internet California California Politics Earthquakes Education Housing & Homelessness L.A. Influential L.A. Politics Mental Health Climate & Environment Climate Change Water & Drought Entertainment & Arts Arts Books Stand-Up Comedy Hollywood Inc. The Envelope (Awards) Movies Musi … nable a layout that focuses on the article. Focus mode Show Search Search Query Submit Search EVENTS MAGAZINES TOP COMPANIES VIDEOS View All Advertisement LA Times Studios Learn more Content produced by LA Times Studios is developed from press releases, announcements and contributor content. Independent of the L.A. Times Newsroom. Questions? Please email [email protected]. Banking & Finance Los Angeles Firm Pelage Pharmaceuticals Raises $120 Million Series B Round for
Rethinking hair loss treatment - BioSpace - Apple Podcasts Search Home New Top Charts Search June 3 22 min Rethinking hair loss treatment BioSpace Play In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients. Host Jennifer C. Smith-Parker, Director of Insights, Bi
Exciting news at Pelage Pharmaceuticals! Thrilled to announce our first patients dosed in the Phase 2a trial, $14M Series A-1 financing led by GV (Google Ventures), and the expert Clinical Advisory… | Christina Weng MD LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices
Pelage Pharmaceuticals – Visionary Ventures Skip to content Visionary Ventures Life sciences venture capital fund investing in ophthalmology and medical aesthetics. HOME OPHTHALMOLOGY FUND Visionary KOLs TEAM Investment Committee Fund Management PORTFOLIO NEWS CONTACT INVESTOR LOGIN Fund Menu Search: HOME OPHTHALMOLOGY FUND Visionary KOLs TEAM Investment Committee Fund Management PORTFOLIO NEWS CONTACT INVESTOR LOGIN Pelage Pharmaceuticals Pelage Pharmaceuticals (Pelage) is a clinical-stage biopharmaceutical company committed to developing first-in-class therapeutic based on breakthrough … ious Previous project: ONL Therapeutics Visionary Ventures is a venture capital fund that invests in life sciences and the future of ophthalmology and medical aesthetics. We are an opportunistic venture fund that invests in early and late stages of a company's growth, from early-stage Series A rounds in clinical trials to late-stage rounds in commercialization. Our target investment range is $5M to $15M. Contact Us Visionary Ventures 620 Newport Center Drive, Suite 650 Newpor … [email protected] Home Ophthalmology Team Investment Committee Visionary KOLs Fund Management Portfolio News Contact Investor Portal Footer Menu © 2019 Visionary Ventures. All Rights Reserved. Go to Top
Pelage Pharma Hair Regrowth: $120M for New PP405 Treatment - Los Angeles Times News Home Page California Election 2024 Housing & Homelessness Politics Science & Medicine World & Nation Business Artificial Intelligence Autos Jobs, Labor & Workplace Real Estate Technology and the Internet California California Politics Earthquakes Education Housing & Homelessness L.A. Influential L.A. Politics Mental Health Climate & Environment Climate Change Water & Drought Entertainment & Arts Arts Books Stand-Up Comedy Hollywood Inc. The Envelope (Awards) Movies Music Televisi … nable a layout that focuses on the article. Focus mode Show Search Search Query Submit Search EVENTS MAGAZINES TOP COMPANIES VIDEOS View All Advertisement LA Times Studios Learn more Content produced by LA Times Studios is developed from press releases, announcements and contributor content. Independent of the L.A. Times Newsroom. Questions? Please email [email protected]. Healthcare & Science Taking Root: Pelage Pharma’s Hair Regrowth Gambit By David Nusbaum Contribu
Pelage Pharmaceuticals Licenses New Technology Practice Areas Team About Firm Profile Business Advisory Preccelerator™ Program Clients Careers DEI Blog Payments Contact Search for June 4, 2019 SA&M Client Pelage Pharmaceuticals Licenses New Technology from UCLA to Combat Hair Loss IP & Technology Transactions Stubbs Alderton & Markiles' client Pelage Pharmaceuticals, a startup company founded by UCLA faculty members Heather Christofk, William Lowry, and Michael Jung, has discovered a new way to activate the stem cells in hair follicles that are responsible for hair growth. This we
Science Pulse - Scientists are actively pursuing... Facebook Вход Публикация Science Pulse Science Pulse Подтвержденный аккаунт 30 январь · Поделился/-ась с Доступно всем Scientists are actively pursuing treatments that do more than slow hair loss. The key idea is to restart growth in follicles that are still present but “stuck” in a dormant state, which is common in androgenetic alopecia, also called male or female pattern hair loss. One of the most publicized recent examples is PP405, a topical small molecule linked to UCLA researchers William Lowry, Heather Christofk, and Michael Jung. UCLA … eeting that threshold. Pelage’s program has attracted major investor backing to fund larger studies. Reuters reported that Pelage raised $120 million and planned to begin late-stage trials the following year to further evaluate PP405 as a non-invasive topical therapy intended to reactivate dormant hair follicle stem cells. Separately, UC Irvine researchers reported a different molecule route involving SCUBE3, a naturally produced signaling molecule made by dermal papilla cell
Heather Christofk Archives | Hair Loss Cure 2020 Skip to content Hair Loss Cure 2020 Search Primary Menu Home About Products Best Laser Hair Growth Devices Hair Research Best Hair Loss Shampoos Contact Us Privacy Policy Search for: Category Archives: Heather Christofk Heather Christofk , Lactate , Mitochondrial Pyruvate Carrier , Pelage Pharmaceuticals , PP405 , William Lowry Pelage Pharmaceuticals Phase 3 Trials for PP405 in 2026 March 28, 2026 admin 1,230 Comments Pelage Pharmaceuticals. I originally wrote this post on Pelage Pharmaceuticals and its PP405 topical hair growth product in 2023. … refore accelerates hair growth. There is a 2015 study from China related to the application of mitochondrial pyruvate carrier blocker UK5099 and its effects on prostate cancer cells. Where can you buy PP405? A number of companies are currently selling their own compounded version of PP405 online. However, this hair loss drug is not yet even officially approved for sale by the US FDA. I would recommend not buying this product from such sketchy vendors, often charging a hefty p
People | Christofk Lab CHRISTOFK LAB research publications photos people contact Principal Investigator Dr. Heather Christofk Professor, Biological Chemistry PhD, Harvard University, 2007 Joined UCLA Faculty in 2008 Searle Scholar Damon Runyon-Rachleff Innovation Award NIH Director's New Innovator Award Dr. Heather Christofk is Associate Director of Basic and Translational Research at the UCLA Jonsson Comprehensive Cancer Center. She is a Professor of Biological Chemistry at the David Geffen School of Medicine and Co-Director of the UCLA Metabolomics Center. Dr. Christofk earned a B.S. at UCLA … . She is a Searle Scholar and recipient of the Damon Runyon-Rachleff Innovation Award from the Damon Runyon Cancer Research Foundation, the NIH Director's New Innovator Award, and an American Cancer Society Research Scholar Award. Along with Drs. Bill Lowry and Mike Jung, Dr. Christofk cofounded Pelage Pharmaceuticals , a company developing metabolism based treatments for alopecia. She serves on the Editorial/Advisory Boards for Cell, Cell Metabolism, Cancer Discovery, PLOS B … ations in nucleotide metabolism affect a variety of human diseases. He hopes to apply a broad foundational training in metabolism and biochemistry to future translational research and surgical practice. Outside of lab, Chris enjoys spending time with his wife, cooking, singing/music, and spending time outdoors (running, hiking, and skiing) or in the gym. [email protected] Norah is a UCLA undergraduate from Goleta, California, majoring in Molecular, Cell, and Developmenta … MD from Tufts University School of Medicine and completed an internal medicine residency at Vanderbilt University. During her residency she worked in Jeffrey Rathmell's lab investigating lipid metabolism in CD4+ T cells. As a PhD student in the Christofk lab, she will be studying the adipocyte-to-mesenchymal-transition that has been implicated in the development of skin fibrosis in systemic sclerosis. Outside the lab, she enjoys spending time with her husband Alex and her da
Pelage Embraces Diverse Patient Recruitment For Non-Hormonal Hair Loss Therapy Get more clinical research insight with our FREE newsletter sign me up Log In or Subscribe Explore Clinical Research Protocol Design & Development Trial Feasibility Site Selection & Activation Patient Recruitment & Enrollment Trial Management Data Management & Analysis Decentralized Trials Regulatory Find Suppliers Consulting & Regulatory CRO Services (Phase I-III) Patient & Site Solutions Software & Services Watch Now STREAM Video Channel Clinical Leader Live Clinical Leader Solutions Ex … ical designed to be applied by the patient. Patients in our trial can store and apply the treatment at home. As with most trials, they do have to go into the clinic at set times for monitoring visits, including assessment for safety and efficacy endpoints. However, for the majority of the trial, they can do the steps from home. Given the prevalence of androgenetic alopecia, are there many competing trials for its treatment? And if so, what are some strategies Pelage used to r … ia Institute of Technology, an MD from Harvard, and she completed a dermatology residency and fellowship at Harvard. Like what you are reading? Sign up for our free newsletter SIGN ME UP I agree to the Terms . I consent to the processing of my personal data for follow-up and B2B marketing communications by Life Science Connect and our trusted sponsors/clients in the life sciences industry. Data Controller: Life Science Connect, LLC I understand I can withdraw consent at any t
Pelage Pharmaceuticals Phase 3 Trials for PP405 in 2026 | Hair Loss Cure 2020 Skip to content Hair Loss Cure 2020 Search Primary Menu Home About Products Best Laser Hair Growth Devices Hair Research Best Hair Loss Shampoos Contact Us Privacy Policy Search for: Heather Christofk , Lactate , Mitochondrial Pyruvate Carrier , Pelage Pharmaceuticals , PP405 , William Lowry Pelage Pharmaceuticals Phase 3 Trials for PP405 in 2026 March 28, 2026 admin 1,230 Comments Pelage Pharmaceuticals. I originally wrote this post on Pelage Pharmaceuticals and its PP405 topical hair growth product in 2023. For all … refore accelerates hair growth. There is a 2015 study from China related to the application of mitochondrial pyruvate carrier blocker UK5099 and its effects on prostate cancer cells. Where can you buy PP405? A number of companies are currently selling their own compounded version of PP405 online. However, this hair loss drug is not yet even officially approved for sale by the US FDA. I would recommend not buying this product from such sketchy vendors, often charging a hefty p … that will utlimately amount to. Phase 2 wasn’t powered for efficacy, the application period was only 28 days, and the growth they saw was after only 3 months. So I will be very interested to see the Phase 3 study design. They seem to be indicating that a longer application period might boost results so I will be curious to see if they extend it and for how long. If you recall, Pelage was initially worried that pushing the pathway too hard could have an adverse effect a … ew follicular units, I think is reasonable and logical to believe that a longer application window (not to mention an evaluation after 6 vs 3 months) could power much better results. Of course, it is just as possible that PP-405 only addresses a piece of a much larger puzzle. Reply LJ says: March 30, 2026 at 8:02 am I don’t think they said anywhere PP405 can create new follicular units, that’s Follica’s proposed mechanism.. Reply admin says: March 30, 2026 a … ely working. D) Something that slid under the radar: dosing was for 28 days BUT application was only every third day. I think that’s a crucial information! E) Of course it doesn’t have to be this way but I assume that daily dosing over 3 months (like in phase 2b) must be dramatically better. Remember that the 120 mil funding was made very quickly
Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss - Pelage Skip to content Home About Science Home About Science Leadership Press Leadership Press Home About Science Leadership Press Home About Science Leadership Press Back to Press Releases Feb 27, 2024 Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss Share: Pioneers novel approach to restore the body’s natural ability to grow hair by reactivating dormant hair follicle stem cells Phase I clin … ing and mentorship awards and is co-director of the Complex Medical Dermatology Fellowship. Clinical Advisory Board Amy McMichael, M.D., F.A.A.D. Professor and Past Chair of Dermatology, Wake Forest School of Medicine Dr. Amy McMichael is a Philadelphia native who received her medical degree from the University of Pennsylvania School of Medicine. She completed Dermatology residency training at the University of Michigan School of Medicine. Dr. McMichael is a Professor in the … She has held leadership positions in the Department for over 20 years first as Residency Program Director for 12 years and Chair of the Department for 11 years. She has been a leader in her field, including her roles as past President of Skin of Color Society and past President of the National Medical Association Dermatology Section. She recently served as a Board member of the American Academy of Dermatology. Dr. McMichael’s clinical and research interests include: hair and … l doctorate from University of California San Francisco, Dr. Hausauer completed residency at New York University then an American Society for Dermatologic Surgery cosmetic surgery fellowship. Leadership Qing Yu Christina Weng, MD Chief Medical Officer Chief Medical Officer Dr. Weng is the CMO of Pelage. She is a physician-scientist and entrepreneur, board-certified dermatologist, and Lecturer at Harvard Medical School. She is experienced in corporate startup strategy as Head … ifornia Institute of Technology, MD from Harvard, and she completed dermatology residency and fellowship at Harvard. Leadership Daniel Gil, PhD Chief Executive Officer Chief Executive Officer Dr. Gil is the CEO of Pelage. He is also a Venture Partner with Visionary Ventures. Until 2018, Dr. Gil was a Vice President at Allergan, overseeing the res
Excited to share the completion of Pelage's Series B financing and our Ph2a clinical study. I am very grateful to the dedicated Pelage team, the patients who have participated in our studies and our… | Daniel Gil | 53 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update
Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team - Pelage Skip to content Home About Science Home About Science Leadership Press Leadership Press Home About Science Leadership Press Home About Science Leadership Press Back to Press Releases Feb 23, 2026 Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team Share: Company expands board of directors and makes key leadership promotions to support upcoming late-stage trials of PP405 in androgenetic alopecia Maykin Ho, Ph.D., appointed to Pelage board of directors Nathan Wheeler … ations and project management, and has successfully supported multiple New Drug Application (NDA), Biologics License Application (BLA) and Marketing Authorisation Application (MAA) submissions. Prior to Pelage, Lisa held roles of increasing responsibility at Kinevant Sciences, Roivant Sciences, and Lexicon Pharmaceuticals. She began her career at The University of Texas MD Anderson Cancer Center in the Office of Protocol Research. Lisa holds a Master’s degree in Business Admi … ing and mentorship awards and is co-director of the Complex Medical Dermatology Fellowship. Clinical Advisory Board Amy McMichael, M.D., F.A.A.D. Professor and Past Chair of Dermatology, Wake Forest School of Medicine Dr. Amy McMichael is a Philadelphia native who received her medical degree from the University of Pennsylvania School of Medicine. She completed Dermatology residency training at the University of Michigan School of Medicine. Dr. McMichael is a Professor in the … She has held leadership positions in the Department for over 20 years first as Residency Program Director for 12 years and Chair of the Department for 11 years. She has been a leader in her field, including her roles as past President of Skin of Color Society and past President of the National Medical Association Dermatology Section. She recently served as a Board member of the American Academy of Dermatology. Dr. McMichael’s clinical and research interests include: hair and … l doctorate from University of California San Francisco, Dr. Hausauer completed residency at New York University then an American Society for Dermatologic Surgery cosmetic surgery fellowship. Leadership Qing Yu Christina Weng, MD Chief Medical Officer Chief Medical Officer Dr. Weng is the CMO of Pelage. She is a physician-scientist and entreprene
Pelage Pharmaceuticals: $14 Million (Series A-1) Raised In Round Led By GV To Address Hair Loss Treatments VC PE M&A Asset Management Law Firms Profiles Contact × Search Pulse 2.0 Pelage Pharmaceuticals: $14 Million (Series A-1) Raised In Round Led By GV To Address Hair Loss Treatments By Amit Chowdhry • Aug 18, 2024 Pelage Pharmaceuticals: $14 Million (Series A-1) Raised In Round Led By GV To Address Hair Loss Treatments Pelage Pharmaceuticals, a clinical-stage regenerative medicine company crearting a new generation of treatments for hair loss, announced that the first patients ha … ple throughout their lives. The study participants will receive a daily topical application of PP405 or a placebo. Participants of all skin phototypes and hair types and textures are eligible. Those interested in participating can find the information at this link. Along with the Phase 2a trial, Pelage announced the formation of its Clinical Advisory Board (CAB), which will support the company’s strategic initiatives as it advances its clinical programs. The newly appoi
Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026 March 18, 2026 | 2 min read Twitter LinkedIn Facebook Email Print LOS ANGELES--(BUSINESS WIRE)-- Pelage Pharmaceuticals , a clinical-stage regenerative m … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
‘We’re Scientists’: Pelage Takes Hair Loss Beyond ‘Lotions And Potions’ - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business ‘We’re Scientists’: Pelage Takes Hair Loss Beyond ‘Lotions And Potions’ February 11, 2026 | 6 min read | Annalee Armstrong Twitter LinkedIn Facebook Email Print iStock, NiseriN A rapturous response to data published last year for Pelage’s hair loss candidate overwhelmed the biote … provide the company with runway all the way to the FDA’s desk with an approval application. Gil said the first part of the year will be spent engaging with the FDA to confirm the trial design and endpoints. Pelage’s mailboxes are overflowing with inbound interest from patients clamoring to get into the Phase III clinical trial for PP405, meaning recruitment won’t be a problem. Weng said this will allow the company to get the population just right to secure an indication in a … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Busine … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Biotech Beach Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine for Hair Loss February 27, 2024 | 5 min read Twitter LinkedIn Facebook Email Print Pelage Pharmaceuticals announced that the company has closed a $16.75 million Series A financing led by GV with par … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Pelage Pharmaceuticals Appoints New Board Member and Expands Executive Leadership Team February 23, 2026 | 4 min read Twitter LinkedIn Facebook Email Print Company expands board of directors and makes key leadership promotions to support upcoming late-stage trials of PP405 in androgenetic alopecia Maykin … ations and project management, and has successfully supported multiple New Drug Application (NDA), Biologics License Application (BLA) and Marketing Authorisation Application (MAA) submissions. Prior to Pelage, Lisa held roles of increasing responsibility at Kinevant Sciences, Roivant Sciences, and Lexicon Pharmaceuticals. She began her career at The University of Texas MD Anderson Cancer Center in the Office of Protocol Research. Lisa holds a Master’s degree in Business Admi … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Busine … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss October 16, 2025 | 6 min read Twitter LinkedIn Facebook Email Print Financing co-led by ARCH Venture Partners and GV (Google Ventures) to support continued advancement of PP405, a top … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Rethinking hair loss treatment - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases P … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Drug Development Rethinking hair loss treatment June 4, 2026 | 1 min read | Jennifer C. Smith-Parker , BioSpace Insights Twitter LinkedIn Facebook Email Print In this episode of Denatured, you’ll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1 - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing De … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1 August 13, 2024 | 4 min read Twitter LinkedIn Facebook Email Print Inclusive trial recruiting women and men with androgenetic alopecia to evaluate safety and preliminary eff … people throughout their lives. Study participants will receive a daily topical application of PP405 or a placebo. Participants of all skin phototypes and hair types and textures are eligible. Those interested in participating can find the information at this link . "GV is encouraged by Pelage's prior Phase 1 data readouts and robust clinical safety profile," said Cathy Friedman , Executive Venture Partner, GV and Board Director, Pelage Pharmaceuticals. "We believe the expert … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Success Inspiration Speaker: Use Project Management Skills to Manage Your Life - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Project Management Keynotes - PMI Virtual Keynote Speech WHY JEREMY VIDEOS BOOKS KEYNOTES WORKSHOPS PMI Virtual Project Management Keynote Speaker Jeremy Gutsche delivered the virtual project management keynote at PMI Virtual on June 15, 2023. Jeremy Gutsche, the CEO and founder of TrendHunter.com, is delivering his newest keynote on the Roaring 2020s and the link between disruption and opportunity. We are currently living through history's highest-ever rate of change. While everyone wants innovation, very few know how to make it happen, falling into the common neurological traps that hin
Find PMO and Project Management Keynote Speakers on The PMO Leader. About About 2026 Annual Conference Engage Community Building Events Share Your Story Explore Books Blog Great Practices Podcast Mentoring Program Podcasts Library Videos Webinars Improve Coaches Consultants Speakers Training Partners PMOpedia Membership Login Speakers Inspire and drive people to action with a respected individual in the Leadership and PMO Communities. Discover your next Keynote Speaker for your special event. These Speakers have a track record of delivering creative, impactful, and thought prov … Anni Finsterer is the author of Radical Rock and Roll Resilience and is an AFI award winning actor, Keynote Speaker and Resilience coach. Since her “Conversations with Richard Fidler” on ABC radio went to air, Anni has been sharing her unique and inspiring story of how she survived two car accidents and insurmountable obstacles and went on to become an actor for some 30 years on stage and screen. Now, she brings her education and lived experience to the REAL RESI … engaging presentation style that ensures they gain the latest knowledge and can apply it to their organisation immediately. Specializing in Digital PPM Solutions, Process Optimization, 100% User Adoption. Learn More about Marc Soester Mounir Ajam Mounir is a thought leader with two passions that drive him to make a difference and create an impact, project management and community development. Speaking expertise in Organizational Project Management, Project Management Met … n 2020 he was awarded the PMO Global Alliance ‘PMO Influencer of the Year Award’. Learn More about Peter Taylor Rich Maltzman I consider myself a ‘pracademic’ – currently Master Lecturer at Boston University, an author, and a consultant, who provides students and clients with a deep, rich learning experience and/or improved results. The ‘prac’-tical part of pracademic comes from a 40-year career in telecom, mainly in engineering and p … the converting weaknesses into strength while teaching clients/students how to apply learned skills to everyday situations. I’ve presented on the topics of Quality and PM, Sustainability, and PM Competency at PMI conferences in the US, Italy, Malaysia, Costa Rica, Canada, and The Netherlands, where I also lived for two years on an internat
Keynote speaker topic – The Future of Project Management – Ross Dawson Home About Clients Keynote speaker Speaking topics Virtual keynotes and presentations Speaker videos Testimonials Global schedule Keynote speaker rankings Keynote speaker associations What is a keynote speaker? Speaker resources Strategy advisor Strategy facilitation Strategic planning workshops Virtual strategy facilitation Reinvention for a post-pandemic world Designing the future of work Amplifying productivity with Humans + AI Scenario planning Industry disruption briefings Strategy offsites Partner offsites
Book a keynote on Project Management | Success Go to main content Skip and go to the footer A-Speakers Search Menu International Speaker Bureau Log in We are ready to guide you. Call us at +1 347 223 5128 or +44 20 3744 5675 Contact +1 347 223 5128 A-Speakers Search for topics, speakers or keynotes Search Speakers Topics Occasions Contact Go Back to the Homepage Topics Project Management Unlocking Success with our Top Project Management Speakers Effective project management is crucial for the success of large-scale projects and those with significant budgets and risks. Not havin … for your event. Your name * Email * Phone Organization Tell us about your event Submit request Call us +1 347 223 5128 +44 20 3744 5675 More about the topic Speakers We're ready to help: +1 347 223 5128 +44 20 3744 5675 Speakers on project management Susanne Madsen An expert in leadership and organisational culture who can give you the right tools to motivate and empower your teams. UK Marga Hoek Harness the power of sustainability to driv … for your event. Your name * Email * Phone Organization Tell us about your event Submit request Unlocking Success with our Top Project Management Speakers In the dynamic landscape of the modern business world, the art and science of project management is necessary to optimize workloads, staying within budgets and ensuring seamless collaboration between parties. Whether you're a seasoned project manager or new to the field, understanding the key principles of project management … for your event. Your name * Email * Phone Organization Tell us about your event Submit request Need help? Phone: +1 347 223 5128 Email: [email protected] Close Receive great offers directly in your inbox Sign up for our newsletter and get regular great offers and inspiration for your events. Subscribe to newsletter We offer keynotes and speakers in all price ranges. Whether it concerns a large event, conference, staff meeting, keynote for the young or elderly or a d
Project Management Keynote Speaker | Leadership Keynote Speaker +1 443.750.1249 [email protected] Check out our latest book ‘Powerful Phrases’ Go Now! --> Leadership Tools In Your Inbox Weekly Home About Karin and David Leadership Development In-person & Live Online Leadership Training Practical Performance Management for Human Centered Leaders Smarter Habits, Faster Wins— The Ultimate Team Building Retreat Leadership Development Programs FAQs Team Transformation Systems SynergyStack® System SynergyStack® Facilitator Certification Human-Centered Leadership Development V … Keynotes with Practical Takeaways Leadership and Communication Experts, Award Winning Authors, and Inc. Magazine Top Keynote Speaker When projects stall, priorities clash, or silence slows progress, project managers need more than process—they need courage, clarity, and practical tools to move work forward. Our interactive keynotes equip project managers and PMO leaders with practical tools to speak up, align quickly, and collaborate effectively. Practical Tools : Cle … feedback from the leaders is that they gained takeaways they could immediately apply in their volunteer and professional roles – including tools and templates. I would hire Karin and David again to improve the skills of people who manage in any capacity.” – Linda Jones, PMI Leadership Institute Courageous Cultures How to build more innovative and courageous project teams What would happen if every member of your project team came to work focused on finding solutions an … peaking Up) and encourage deeper dialogue up, down and sideways A plan they can apply right away Karin or David will inspire your team with real examples of turnaround successes and powerful tools from their executive roles and their work with companies around the world. Your audience will leave with tools and techniques they can immediately apply with their teams from this project management keynote. You can download the first few chapters of their book, Courageous Cultures … ded to speak at any event seeking interaction, practical knowledge and relevant application for any organization.” – Roy Burton , Chief Financial Officer, PMIWDC, Ass’t Director, Treasury Inspector General Can We Talk for Real? Practical Tools and Techniques for Courageous Conversations In every workplace, there are moments that matter—when
Instagram Instagram Log In Sign Up Close Never miss a post from christina.qyw Sign up for Instagram to stay in the loop. Sign up Log in Tags iflscience christina.qyw • Follow More options christina.qyw Edited • 55w @iflscience Load more comments jojosheu 56w 👏👏👏 Like Reply Like Comment 1 Share Save May 3, 2025 Log in to like or comment. More posts from christina.qyw Clip Carousel Carousel Carousel Carousel Carousel Carousel Carousel See more posts Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified Engl
Instagram Instagram Log In Sign Up Close Never miss a post from christina.qyw Sign up for Instagram to stay in the loop. Sign up Log in christina.qyw • Follow Original audio More options Load more comments archie_salvatore 9w When is phase 2b getting presented? Like Reply Like Comment 1 Share Save March 30 Log in to like or comment. More posts from christina.qyw Clip Carousel Carousel Carousel Carousel Carousel Carousel Carousel See more posts Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Dow
Our Team — Leadership Partners Home Who We Are Our Team Client Experience What We Do Services Overview Leadership Development Team Building Optimizing Meetings Meeting Customer Needs Strategy Planning Learning Tools Everything DiSC 5 Behaviors Contact Home Who We Are Our Team Client Experience What We Do Services Overview Leadership Development Team Building Optimizing Meetings Meeting Customer Needs Strategy Planning Learning Tools Everything DiSC 5 Behaviors Contact Who We Are Our Team Client Experience We’re an experienced team of human resources, employee engagement, and leadership p
#leadership #leadwithcourage #keynotespeaker | Kim "KC" Campbell | 26 comments LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn
Our Team — Leadership + Design 0 Skip to Content Who We Are Mission and Values Our History Our Team Our Board Our Clients Careers Contact Us Services Building Teams + Culture Clarifying Identity Creating Strategy Redesigning Programs Programs CultureLab L+D Fellowship Wonder Women Leadership Lab Design Your Journey L+D Expedition L+Doers Unite! (Membership) Leadership Coaching articles impact report Shop/Register Open Menu Close Menu Who We Are Mission and Values Our History Our Team Our Board Our Clients Careers Contact Us Services Building Teams + Culture Clarifying Identity Creating S … rifying Identity Creating Strategy Redesigning Programs Programs CultureLab L+D Fellowship Wonder Women Leadership Lab Design Your Journey L+D Expedition L+Doers Unite! (Membership) Leadership Coaching articles impact report Shop/Register Open Menu Close Menu Folder: Who We Are Back Mission and Values Our History Our Team Our Board Our Clients Careers Contact Us Folder: Services Back Building Teams + Culture Clarifying Identity Creating Strategy Redesigning Programs Folder: P … ity Creating Strategy Redesigning Programs Folder: Programs Back CultureLab L+D Fellowship Wonder Women Leadership Lab Design Your Journey L+D Expedition L+Doers Unite! (Membership) Leadership Coaching articles impact report Shop/Register Our Team Antonio Viva Antonio Viva is a Partner at Leadership+Design, where he works with schools, nonprofits, and mission-driven organizations at moments of transition, growth, and strategic inflection. His work focuses on strategic plannin
Leadership Team | Thayer Leadership Thayer Leadership, Building Leaders of Character LinkedIn Facebook YouTube Contact Approach Approach Agile leaders, cohesive teams, and resilient organizations are cultivated by focusing on the growth of character and knowledge, and practical application. Our foundation for leadership development is based on 250 years of proven experience from the U.S Army and West Point, delivered by world-class faculty in inspirational locations. Philosophy Faculty Locations Solutions Results Solutions Solutions Customized leadership journeys are tailored to your unique ne … dership Advisory Committee Faculty Results Veteran Support Patriots in Business Award Annual Veterans Day Event Military Spouse Employment Search Thayer Leadership Contact Search Thayer Leadership Search Close Site Search Approach Solutions Resources About Us Back Approach Philosophy Faculty Locations Solutions Results Back Solutions Areas of Expertise Custom Programs Open Enrollment Programs Keynotes Coaching / Assessments Client Success Back Resources Videos Leadership Blog … Leadership Advisory Committee Faculty Back Veteran Support Patriots in Business Award Annual Veterans Day Event Military Spouse Employment LinkedIn Facebook YouTube Contact Leadership Our dynamic leadership team consists of purpose-driven leaders of character who shape vision and strategy, foster innovation, drive growth, and uphold a commitment to excellence in every aspect of operations. Leadership Meet The Team Karen Kuhla McClone, PhD Co-President, Thayer Leadership Rick … in your browser to complete this form. Name * First Last Email * gclid UTM UTM Submit Follow Us LinkedIn Facebook YouTube ©2026 Thayer Leadership, Inc. All Rights Reserved. "Thayer Leadership" is a registered trademark of Thayer Leader Development Group, Inc. Privacy Policy Terms and Conditions Website by: Hawthorn Creative DISCLAIMER: This private organization is a non-federal entity and not an official activity of the United States Military Academy. It is not endorsed
Team Leadership – Blanchard Greece SLII Powering Inspired Leaders™ Contact Us What We Do Who We Help Who We Help Leaders At All Levels Emerging Leaders New Managers Experienced Leaders Senior Leaders Executives Who We Help Organizations Training Professionals Coaching Professionals Who We Help Teams Individuals Students Our Content Our Content Programs SLII®. Powering Inspired Leaders™ Blanchard Management Essentials® Building Trust Coaching Essentials® Conversational Capacity® Courageous Inclusion™ Essential Motivators™ See All Programs Our Content Organizations Leadership Point of View … training course teaches managers to diagnose their team’s development and apply the right leadership style to build and sustain high-performance teams. By teaching managers these leadership skills, you can significantly improve your teams’ ability to execute on projects, grow the business, and develop agility that allows them to adapt to whatever arises. Talk to an Expert Invest in team leader training and tap into every team’s potential We know you want your team … PRACTICE — Practice mindset and skillset through interactive assignments Day 1 Apply — Reintroduces and summarizes the high-performance team road map. Introduces the action plan Post Work: APPLY — Revisit the learning portal and access tools, including the Teams Assessment multi-rater Report, Teams Assessment Interpretation Guide Team, and Charter Worksheets. Virtual Virtual Instructor-led Course The Team Leadership virtual course is presented in three two-hour sessions. The
For Teams | The Dr. Nancy Grasmick Leadership Institute | Towson University --> Skip to Main Content Impact Contact Us About For Individuals For Teams Menu About For Individuals For Teams Impact Contact Us The Dr. Nancy Grasmick Leadership Institute For Teams For Teams The most powerful transformation occurs when leadership development is not exclusive to a few individuals, but is mobilized throughout your organization at every level. Sub-menu For Teams Our Portfolio Coaching Speaking Requests We work with leaders, teams and organizations to develop human-centered, results-based solutions. We
Team Leadership for Managers Workbook | Best Practices - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Scott Greenberg | Keynote Speaker | AAE Speakers Bureau 1.855.383.8805 Contact Us Speakers Topics Business Strategy Cybersecurity Diversity and Inclusion Education FinTech Future of Work History Leadership Mental Health Motivational Politics Social Activism Sports STEM Sustainability and Climate Change Work Life Balance >> View All Topics Resources About Contact Us 1.855.383.8805 Home Speakers Scott Greenberg Scott Greenberg 12 ratings Keynote Speaker: Business Consultant Specializing in Entrepreneurial Leadership, Team Dynamics & Operational Performance; Author of "The Wealthy … s franchisees think, lead and serve at a higher level. With over 10 years as an award-winning, multiunit franchisee and coach for countless brands, he will show you HOW top franchisees achieve consistent, profitable results (beyond doing more marketing and finding better employees). In this engaging, practical keynote program, Scott will show you how to: THINK like a high performer. Take control of your brain to ensure your mindset is an asset to the organization, not a detri … rtually any speaker or celebrity in the world. Our agents are happy and able to submit an offer to the speaker or celebrity of your choice, letting you benefit from our reputation and long-standing relationships in the industry. Please click the Check Schedule button above and complete the form on this page including the details of your event, or call our office at 1.855.383.8805 , and one of our agents will assist you to book Scott Greenberg for your next private or corporat … s franchisees think, lead and serve at a higher level. With over 10 years as an award-winning, multiunit franchisee and coach for countless brands, he will show you HOW top franchisees achieve consistent, profitable results (beyond doing more marketing and finding better employees). In this engaging, practical keynote program, Scott will show you how to: THINK like a high performer. Take control of your brain to ensure your mindset is an asset to the organization, not a detri … rtually any speaker or celebrity in the world. Our agents are happy and able to submit an offer to the speaker or celebrity of your choice, letting you benefit from our reputation and long-standing relationships in the industry. Please click the Check Schedule button above and complete the form on this page including the details of your event, or
The Learning Moment Skip to content Toggle Navigation HOME ABOUT MEET GARRY QUIZ HOW WE WORK TOGETHER SPEAKING COACHING VIDEOS BLOG LET’S GET STARTED Toggle Navigation HOME ABOUT MEET GARRY QUIZ HOW WE WORK TOGETHER SPEAKING COACHING VIDEOS BLOG LET’S GET STARTED Home DustinPesavento 2026-03-25T14:55:25+00:00 Stop Managing, Start Leading. Managing is easy. Bossing people around takes no talent. Leading is harder. It takes empathy, courage, and a healthy dose of humility. But, any dumb-ass can do it, and it’s the work I’ve dedicated my life to. HOW WE WORK TOGETHER GET IN TOUCH Stop … st Name * Phone * What are you interested in? Speaking Coaching Media Message * Submit Thank you for your message. It has been sent. × There was an error trying to send your message. Please try again later. × ABOUT MEET GARRY CONTACT WORKING TOGETHER SPEAKING COACHING MEDIA VIDEOS BLOG QUIZ LEGAL DISCLOSURE TERMS OF USE PRIVACY POLICY The insights, experiences, and perspectives I share on my website and in my writing and speaking engagements reflect my leadership
Innovation & Leadership Keynote Speaker | John Rossman SPEAKING BOOKS RESOURCES Leadership Blog More about John Free Download Amazon Leadership Principles MEDIA Contact Select Page From Launching the Amazon Marketplace to Your Next Big Bet Strategies from the architect of 62% of Amazon’s sales – now a 4x Best-Selling Author and advisor to top leaders. Check Availability & Fees From Launching the Amazon Marketplace to Your Next Big Bet Strategies from the architect of 62% of Amazon’s sales – now a 4x Best-Selling Author and advisor to the world’s top leader
Dr. Michael Jung PT, DPT - Highbar Physical Therapy Skip to main content Skip to footer Explore Career Opportunities at Highbar Physical Therapy For Patients For Patients Physical Therapy Schedule an Appointment Find a Location Blog Insurance CONDITIONS Low Back Knee Neck Shoulder Hip Request an Appointment Physical therapists are experts in movement and are trained to uncover issues, diagnose conditions, create a treatment plan, and educate patients on how to take care of their bodies. Schedule An Appointment Students Students Clinical Rotation Information Physical Therapy Continuing Educatio … n Education COMT COPTA Core-4 Series Labs Dry Needling Certification Orthopedic Residency Region-Focused Certifications Weekend Lab Intensives Explore Careers Opportunities Careers Life at Highbar Careers Open Positions Continuing Education Join Our Team We're building a culture where physical therapists thrive. Join a team that's passionate about transforming lives and raising the standard for patient care. Explore Careers Opportunities About About Us Our Story Our Physical
Instagram Instagram Log In Sign Up Close Never miss a post from marsequestrian Sign up for Instagram to stay in the loop. Sign up Log in marsequestrian and 3 others Original audio More options marsequestrian Verified Edited • 57w Congratulations to Michael Jung & FischerChipmunk FRH on a history victory at the @kentuckythreedayevent presented by MARS Equestrian. 🏆 Load more comments usrider_equine 57w 👏🏻👏🏻👏🏻 Like Reply spaldinglabs 57w Congratulations! Like Reply eqauri 57w The lack of wither clearance is burning my eyes. Loves his horses? Nope, not according to this 1 like Reply eq
Michael Jung - OCIO Connect 2018 This event has ended. Visit the official site or create your own event on Sched . OCIO Connect 2018 Hosted by the Office of the Chief Information Officer, OCIO Connect offers a valuable opportunity to gain new perspectives on what’s happening in the world of technology. Business leaders, IT professionals and decision makers from across government will learn about important new technologies, trends and best practices from across the global IT space, as well as the ways that the B.C. Government is embracing technology to tackle business challenges and deliv
Michael Jung still on top at the Defender Kentucky Three-Day Event presented by MARS Equestrian™ - The Plaid Horse Magazine Never Miss a Beat Sign up for our email newsletter MAGAZINE PLAIDCAST BLOG Barn Lounge Bay Broadcast Breeding Collegiate Corner Hunter Hack Jump Off Junior Ring Literature Selections Outside the Ring Partial Board Pony Island Stallion Alley Tack Room Trainer Tuesday PRESS RELEASES SUBSCRIBE Advertise With Us ABOUT TPH OUR TEAM CONTACT TPH Search Current Issue Gift Guide Write for Us! Summer Internship Sign in Welcome! Log into your account your username your password Forg … of the competition – Dressage, Cross-Country and Show Jumping – for $400,000 in prize money to those competing at the CCI5*-L level. K3DE is the largest and longest-running Five Star event in the Americas and as the United States’ premier event, it also serves as the Defender/USEF CCI5*-L Eventing National Championship presented by MARS Equestrian for the U.S. athletes. Rolex is the Official Timepiece and Event Partner. Cosequin ® Lexington CCI4*-S Introduced in 2021, the Cos … ngton 4*-S is a US Equestrian Open Eventing Series Qualifier and offers $50,000 prize money. Tickets for viewing the Cosequin ® Lexington 4*-S are included when purchasing the K3DE tickets. Kentucky International CSI5* presented by Hagyard Equine Medical Institute Formerly known as the Kentucky Invitational, the Kentucky International made its debut at the 2018 Kentucky Three-Day Event as a CSI3* and was held as a CSI4* for the first time in 2024. As a CSI5* in 2025, the inte
View Speaker: michael-jung :: SayIt 首頁 Home 講者 Speakers 對話 Speeches / 分享 Share Michael Jung 1 出現次數 Appearances 9 發言數 Speeches 4 th of 60 speakers --> "Another funny story is, I actu..." 最長發言 Longest speech 發言 Speeches 2024-03-18 Conversation with ICF I have a very interesting story about hacking. You know, when you think of hackers, you think of someone without any morals, no civic responsibility whatsoever. 前後文 Link in context 連結 Link 2024-03-18 Conversation with ICF However, in Toronto, where we’re from, there was a cyber-attack on our sick kid’s hospital. And they locked them out
Michael Jung and fischerChipmunk FRH put down a record breaking test at the Defender Kentucky Three Day Event presented by MARS Equestrian, heading into cross country on only 18.6 penalties. Defender | Mars Equestrian | USEF Network
Speaker Details: 2025 CRE Summit and tags on every page of your site. --> and tags on every page of your site. --> x Speaker Details Full Name Michael Jung Job Title Co-Founder and Managing Partner Company Grit Road Partners Speaker Bio Michael Jung is Co-Founder and Managing Partner of Grit Road Partners (www.gritrd.com). Since early 2020, Mr. Jung has been focused on creating, developing, and launching the Grit Road Partners. Grit Road is a Midwest-based investment platform that invests seed capital in high-growth AgTech start-ups, focused on solving Midwest producer problems. Since its laun
Conversation with Main Stage Speaker: Michael Jung – OneCape Skip to main content Scroll Top Primary Menu Primary Menu Home 2024 OneCape Summit 2023 OneCape Summit 2022 OneCape Summit 2021 OneCape Summit 2019 One Cape Summit 2018 OneCape Summit The Sandbox OneCape Breakout Session Conversation with Main Stage Speaker: Michael Jung   September 18, 2024 | 11:45 A.M.   Dune Middle Room, Dune Building Session Description: Participants will have the opportunity to ask questions and engage in conversation with Michael Jung following his plenary session remarks.
Behind the Barn 2025: Michael Jung Competition Results Official Event Programs Defender Kentucky Three-Day Event CCI5*-L Cosequin® Lexington CCI4*-S The Kentucky International CSI5* Plan Your Visit K3DE App Scavenger Hunt Accommodations Food & Dining What to Wear Bringing Your Dog Shopping The Three-Day Shop Sponsor Village & Courtyard Trade Fair The Hill Sponsors CCI5* and CCI4* Sponsors The Kentucky International CSI5* Sponsors Sponsorship Opportunities Media Press Room Behind the Barn Best Weekend Blog Inside Kentucky Podcast Gallery About KY Three-Day Event History Equestrian E … rd books as just the second American in nearly two decades to take home the top prize. He and Diabolo added just 0.8 time penalties in the final phase to finish on a score of 28.1 and take home the trophy. Double-clear show jumping rounds propelled Caroline Pamukcu and HSH Blake (28.6) and Great Britain’s David Doel on Galileo Neiuwmoed (30.8) to 2 nd and 3 rd respectively. Overnight leader, New Zealand’s Monica Spencer and Artist, dropped three rails to fall to 7
Instagram Instagram Log In Sign Up Close Never miss a post from thevfoundation Sign up for Instagram to stay in the loop. Sign up Log in thevfoundation Verified • Follow Original audio More options thevfoundation Verified 19w What can young people do to prevent cancer? Our researcher, Dr. Heather Christofk, shares. Load more comments speakerjoyhuber 19w Great information - thank you! I was diagnosed at age 33 & it was stage 4 cancer. 😮💔😢 But thanks to advances in treatment made possible by the research funded by the V Foundation I’m not only still here but thriving almost 16 years after
Instagram Instagram Log In Sign Up Close Never miss a post from uci_cancerresearch Sign up for Instagram to stay in the loop. Sign up Log in uci_cancerresearch • Follow More options uci_cancerresearch 212w Another successful Campus-Wide symposium on basic cancer research done! Thank you Dr. Heather Christofk for coming down from UCLA and giving our keynote address. Thank you to all our UCI presenters: Dr's. Lauren Albrecht, Chris Hughes, Charles Limoli, Thomas Martinez, and Selma Masri. All of them gave wonderful talks covering the latest of their cancer research. Thanks to @thepizzabaker
#bmh2024 | The IUBMB LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement , Privacy Policy , and Cookie Policy . Skip to mai
Conference Speaker articles: Cell Symposia: Metabolites: organellar communication in health and disease Speaker articles Take a look at what some of our Metabolites: Organellar communication in health and disease speakers have published recently and chat with them about their work in Sitges, Spain. Keynote speakers Nav Chandel , Northwestern University, USA Mitochondrial respiration in microglia is essential for response to demyelinating injury but not proliferation Mitochondrial integrated stress response controls lung epithelial cell fate Heather Christofk , University of California, Los Ang … inflammation through interorganellar contacts and mitochondrial DNA mislocation Submit your own research here .
Focus On: Cancer Metabolism - Sanford Burnham Prebys Skip to content 0% --> Sanford Burnham Prebys Primary Menu Research Research Overview Disease-Focused Centers Research Disease-Focused Centers NCI-Designated Cancer Center Research NCI-Designated Cancer Center Overview Shared Resources Community Advisory Board Collaborations Leadership Training Events Center for Cardiovascular and Muscular Diseases Center for Neurologic Diseases Center for Metabolic and Liver Diseases Enabling Technology Centers Research Enabling Technology Centers Center for Therapeutics Discovery Research Center for Therap … g Opportunities Ways to Give Create a Legacy Donate Now Contact Us You can help fund the next breakthrough Creating a better world with your support. About About Overview Leadership About Leadership Management Scientific Administrative Board of Directors Officers Scientific Advisory Board Careers About Careers Overview Current Openings Benefits Culture and Values Life in Our City Our History Our Community Media Resources Publications Donate Dedicated to human disease and adva
Heather Christofk | UCLA Health Jonsson Comprehensive Cancer Center Skip to main content Explore links (header) { leftIsLimited = ($el.getBoundingClientRect().left) Explore UCLA Health UCLA Health Home Clinical Departments School of Medicine Simms Mann Center Hospitals & Clinics News & Insights Community & Equity Universal links (header) myUCLAhealth Contact Us 888-662-8252 Translate English العربية 中文 Italiano 日本語 한국어 فارسی Русский Español Tiếng Việt Translate English العربية 中文 Italiano 日本語 한국어 فارسی Русский Español Tiếng Việt Search Search Try looking up a doctor, a clinic locat … umerous honors for her research, including the Damon Runyon-Rachleff Innovation Award, the NIH Director's New Innovator Award and an American Cancer Society Research Scholar Award. Christofk earned her BS degree from the University of California, Los Angeles, in Molecular, Cell and Developmental Biology in 2001. She earned her PhD degree from Harvard University in 2007 under the mentorship of Dr. Lewis Cantley, current Director of the Sandra and Edward Meyer Cancer Center at
Home | Christofk Lab CHRISTOFK LAB research publications photos people contact Metabolism in human health and disease Tissue Stem Cells Cancer Development CLICK HERE news August 18, 2025 Heather discusses her work that led to Pelage Pharmaceuticals on KCAL news! July 30, 2025 Chris is awarded the Tumor Cell Biology T32 Grant! July 9, 2025 Chris passes his oral qualifying exam and advances to Doctoral Candidacy! July 1, 2025 Arissa completes her rheumatology fellowship and becomes a clinical instructor in the Division of Rheumatology! June 25, 2025 Arissa is awarded the Bevra Hahn M.D. Rheumato … Rheumatology! June 25, 2025 Arissa is awarded the Bevra Hahn M.D. Rheumatology Fellowship Award! June 23, 2025 Arissa is awarded the American College of Rheumatology Distinguished Fellow Award! May 30, 2025 Julia is awarded the UCLA Center for Reproductive Science, Health and Education Research Fellowship! May 23, 2025 Sara passes her oral qualifying exam and advances to Doctoral Candidacy! May 22, 2025 Julia is awarded the Behrensen - Guzmán Palma Award for her doctoral wor … at Stowers Institute! May 12, 2025 Congrats to Houfu on receiving the Zamenhof Scholarship! May 11, 2025 Heather gives Keynote Address at Cell Symposium on Metabolites: organellar communication in health and disease March 21, 2025 Heather is honored to give the Gina Lee Memorial Keynote Lecture at the SoCal Metabolism Symposium October 21, 2024 Congrats to Blake for signing his faculty job offer - the Wilde lab will be starting in January at Roswell Park Comprehensive Cancer … well Park Comprehensive Cancer Center! October 4, 2024 Sara is awarded a poster prize at the 3rd Fusion Metabolism in Health & Disease Conference! August 6, 2024 The lab is awarded a UH2 grant from the National Cancer Institute to fund Sydney's project studying the role of dietary lipids in pancreatic cancer development! August 7, 2024 The Christofk Lab has a TikTok account! July 25, 2024 Heather's Cell Voices piece is featured in Cell's 50th anniversary in 2024- Metabolism S … nd renal cell cancer! July 1, 2024 Sara Frigui is awarded the BSCRC Predoctoral Fellowship! May 8, 2024 Houfu's poster wins 1st place postdoc poster at the Jonsson Comprehensive Cancer Center Symposium! Dec 8, 2023 Cesar's paper on fetal development and maternal diabetes is spotlighted by UCLA! Dec 8, 2023 Cesar’s paper on fetal metabolism in dia
Daniel Gil aka Kingdom Ninja – Warriors On A Mission Skip to content Home About Line-up Get Tickets Contact Us Sponsors and Donations Home About Line-up Get Tickets Contact Us Sponsors and Donations Blog Daniel Gil aka Kingdom Ninja Favorite Bible verse: Matthew 6:33 “B ut seek first his kingdom and his righteousness, and all these things will be given to you as well.” Favorite Quote: “Today I will do what others won’t, so that tomorrow I can accomplish what others can’t.” – Jerry Rice Seasons on American Ninja Warrior: I have competed
About - Daniel Gil Skip links Skip to primary navigation Skip to content Toggle navigation Home About Books How To Be A Kingdom Ninja Speaking Shout Out Training Media Contact Shop Shop Daniel’s Biography Season 12 Champion & Stage 4 Finisher of American Ninja Warrior I’m a professional ninja athlete and a nine-time National Finalist on American Ninja Warrior. Discover More About Me Daniel’s Mission To be a role model and example of a life of love and discipline, using obstacles to make a positive impact in the world. My hope is to encourage others to discover their callings an
American Ninja Warrior Daniel Gil at Hidden Valley Community Church - LIFE 102.5 American Ninja Warrior Daniel Gil at Hidden Valley Community Church - LIFE 102.5 Drive-thru Difference Pray Business Partners About show submenu for “About” Mission Careers Contact Search Looking for a song? Search results: Sorry, but nothing matched your search terms. Listen show submenu for “Listen” Back Listen How to Listen Music Podcasts On-Air Personalities Listen Live Back Music Music Recent Artists Songs Download the app Attend show submenu for “Attend” Back Attend Events Concerts Station Events Connect sho … There’s always something fun to do in our community! Discover opportunities for fellowship, outreach, and more. See more Heard on Air New article Kindness Is Contagious: 6/3/26 Sarah Tachon from Kindness Is Contagious says: Remember this about our teachers: “A teacher takes a hand, touches a heart, and shapes a future.” Get started New article Tim Markle’s Forgiveness Factor: 6-2-26 Tim Markle shares that forgiveness is learning to follow God even when life—and family—isn’t p
Meet Daniel Gil | OCR Athlete & Motivational Speaker – SHOUTOUT DFW Skip to content About Us Privacy & Terms of Service Nominations Log in Instagram Lifestyle Unique Perspectives Work & Life Tech & Culture Lifestyle Unique Perspectives Work & Life Tech & Culture Local Stories Meet Daniel Gil | OCR Athlete & Motivational Speaker February 14, 2023 February 8, 2023 Leave a reply We had the good fortune of connecting with Daniel Gil and we’ve shared our conversation below. Hi Daniel, why did you pursue a creative career? I chose to pursue a more creative ca
Kingdom Ninja | Daniel Gil - YouTube Info Presse Urheberrecht Kontakt Creator Werben Entwickler Impressum Verträge hier kündigen Nutzungsbedingungen Datenschutz Richtlinien & Sicherheit Wie funktioniert YouTube? Neue Funktionen testen © 2026 Google LLC
Kingdom Ninja - Kingdom Ninja Skip to content Preorder the Kingdom Ninja book and get free family workout videos from Daniel! LEARN MORE HERE Preorder the Kingdom Ninja book and get free family workout videos from Daniel! LEARN MORE Welcome to the world of the The online home of Daniel Gil 2020 American Ninja Warrior Grand Champion 7x ANW Competitor Speaker, trainer, worshiper Devoted husband and Jesus follower Kingdom Ninja—the Book Daniel Gil’s unprecedented rise from American Ninja Warrior rookie to grand champion didn’t happen overnight, much like the healthy habits he’s developed over the
American Ninja Warrior Event with Daniel Gil - Project Nation (88.7) Boise, Idaho Skip to content Text Us 24/7 - 855-811-LIVE Listen Live Give Now Store Free Stickers Instagram page opens in new window Viber page opens in new window Facebook page opens in new window YouTube page opens in new window X page opens in new window Project Nation (88.7) Boise, Idaho Live Connected, CHH Christian Rap, Pop Radio Feel Good Shows Mornings with Mysti Middays with A Rich Afternoons With Milton Evenings With Jeff Turner Weekends With Kevin Segments Project Top 5 Wild Jesus Crew Ask TJ Podcasts Wake Up! Podc … uragement Store Events Upcoming Events Community Calendar View Community Events Submit An Event Give Give Now Day Sponsor Project VIP Premiere Fred Meyer Rewards Program Donor Login Control Freaks Connect About Project Get Prayer Text Us Email Newsletter Download App Artist Directory Partners Now Playing --> Feel Good Shows Mornings with Mysti Middays with A Rich Afternoons With Milton Evenings With Jeff Turner Weekends With Kevin Segments Project Top 5 Wild Jesus Crew Ask TJ … uragement Store Events Upcoming Events Community Calendar View Community Events Submit An Event Give Give Now Day Sponsor Project VIP Premiere Fred Meyer Rewards Program Donor Login Control Freaks Connect About Project Get Prayer Text Us Email Newsletter Download App Artist Directory Partners American Ninja Warrior Event with Daniel Gil You are here: Home Event American Ninja Warrior Event with… Date Apr 25 2024 Expired! Time 5:00 PM - 8:30 PM American Ninja Warrior Ev
HUGE NEWS!... - Our Savior's Lutheran Church Moorhead Facebook Вход Публикация Our Savior's Lutheran Church Moorhead Our Savior's Lutheran Church Moorhead 13 январь · Поделился/-ась с Доступно всем HUGE NEWS! Daniel Gil -- American Ninja Warrior and Motivational Speaker is coming to OSLC on Wednesday, April 22nd. More info coming later.... but you are invited for free to see/listen to/meet him! I am especially excited about this because I've wanted to bring him in for a couple years and it's finally happening!! I've attached some pictures of my girls with him at v
Speaking - Daniel Gil Skip links Skip to primary navigation Skip to content Toggle navigation Home About Books How To Be A Kingdom Ninja Speaking Shout Out Training Media Contact Shop Shop Daniel, As A Speaker Book Daniel Now How Daniel began a career as a speaker? Daniel has always been an encourager! Passionate, articulate and able to simplify any topic to meet an extremely wide range of audiences. He truly has a heart for people and has had a passion to inspire and motivate those around him his entire life. Over the last decade he has found a way to use his natural gift in collaboration wit
Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Jo … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search Press Releases Pelage Pharmaceuticals Announces Positive Phase 2a Clinical Trial Results for PP405 in Regenerative Hair Loss Therapy June 17, 2025 | 5 min read Twitter LinkedIn Facebook Email Print Clinical validation of stem cell reactivation approach positions Pelage as leader in regenerative medicine and aging LOS AN … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
A regenerative therapy for hair loss attracts a mega-fundraising round | BioPharma Dive Skip to main content CONTINUE TO SITE ➞ Don't miss tomorrow's biopharma industry news Let BioPharma Dive's free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy . You can unsubscribe at anytime. Informa TechTarget | Healthcare Dive MedTech Dive PharmaVoice Xtelligent Pharma Life Scienc
mitochondrial pyruvate carrier - Page 1 | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscape PFA re-energizes afib mar … p of investors to the table in an oversubscribed $120 million series B round to fund an upcoming phase III program for PP-405, a topical small molecule targeting hair follicle stem cells. Read More Popular Stories Today's news in brief BioWorld BioWorld briefs for June 4, 2026. ASCO 2026: A revolution in pancreatic cancer BioWorld At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the d
%PDF-1.7 %���� 1 0 obj >/Metadata 956 0 R/ViewerPreferences 957 0 R>> endobj 2 0 obj > endobj 3 0 obj >/ExtGState >/ProcSet[/PDF/Text/ImageB/ImageC/ImageI] >>/Annots[ 33 0 R 34 0 R 35 0 R 36 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R 49 0 R 50 0 R] /MediaBox[ 0 0 612 792] /Contents 4 0 R/Group >/Tabs/S/StructParents 0>> endobj 4 0 obj > stream x��][oG�~7�����`ծ{u Me��`6c�!�ǡma%+)�ɿ�:����M�,ڻdQd���ԩs�Υ�Wo~yw�]_��f��뎼�˻��������o.W��������/HO����#���kú�����cw����ۗ/^�Ҏ����퇗/���t�Ӭ'Lt��^���O�������#�S �}ķ����^������]�.����ݥ�x|wy�/~���?��?���������[;��/_ :QV�(U� T>QS#n2]9P��fӽZ? �W��o��#o �
SBIR/STTR Equipment Budgeting: A Practical Guide for Grant-Funded Labs Skip to Main Content Leasing Program Partner Network About Us Leasing Program About Us Partner Network FAQs Resources Blog The Biotech Startups Podcast Equipment Leasing Solutions Analytical Instruments Biotech & Life Sciences Equipment Chromatography Equipment Clinical Lab Equipment General Lab Equipment Lab Safety Equipment Microscopes Spectroscopy Equipment See All Equipment Categories Contact Us LinkedIn Spotify Apple Podcasts YouTube Contact Us Home / Blog / SBIR/STTR Equipment Budgeting: A Practical Guide for Gran … s, and life science teams. SBIR/STTR Equipment Budgeting: A Practical Guide for Grant-Funded Labs Last Updated on July 16, 2025 By Excedr Table of Contents H2 heading Other Posts About Life Sciences Funding Electra Therapeutics: Pioneering SIRP-Targeted Therapy NewLimit: Using Epigenetic Reprogramming to Reverse Cellular Aging Pelage Pharmaceuticals: Pioneering Stem Cell Therapy for Hair Loss See All Blogs Getting SBIR or STTR grant funding is a huge milestone—but spending it … ngful data. But budgeting for that equipment—and justifying it properly in your grant application—can be trickier than it seems. SBIR/STTR grants come with specific rules around direct and indirect costs, allowable expenses, and how equipment must be categorized and documented. Missteps can delay your award, trigger audits, or undermine your commercialization plan down the line. In this guide, we’ll walk through how to plan, budget, and procure lab equipment using SBIR and ST … equipment using SBIR and STTR funds—whether you're applying for a Phase I award or expanding operations under Phase II. We’ll cover key cost principles, budgeting strategies, and procurement tips that can help you stay compliant and move your research forward. Why Equipment Planning Is Critical for SBIR/STTR-Funded Labs In the rush to get a grant application out the door, it’s easy to treat equipment budgeting as just another line item. But for labs funded through the S … nt goals. Overspending—or misallocating—on equipment in Phase I could make your proposal less competitive. Under-budgeting in Phase II could leave your team scrambling to meet project milestones. Either way, unclear or poorly justified costs can raise red flags for reviewers and subject matter experts tasked with evaluating your plan. Done right,
🎉... - California NanoSystems Institute at UCLA Facebook Вход Публикация California NanoSystems Institute at UCLA California NanoSystems Institute at UCLA 10 октябрь 2025 г. · Поделился/-ась с Доступно всем Congratulations to Pelage Pharmaceuticals, a company within our Magnify Incubator, for being named to TIME ’s Best 100 Inventions of 2025! Pelage’s innovative therapy, PP405, is a topical, non-hormonal treatment that activates dormant stem cells in hair follicles to regrow hair—addressing the underlying biology of balding rather than its symptoms. This groundbreaking approach represents a
Hair loss pipeline looking thicker as investors plough $270 million into a cure for balding | The Pharmaletter Thursday 4 June 2026 About Contact Login VC & Investment M&A AI Podcasts News Pharmaceutical News Biotechnology News Generics News Biosimilars news In Brief Legal Company Pages In The Boardroom Insights Analysis Special Report Interviews Expert View From Our Correspondent One To Watch Companies Digital Pharma Pharma Leaders Regulatory FDA EMA Pricing, Reimbursement and Access Regulation Government Affairs Trump Administration Therapy Areas Dermatologicals Oncology Neurological … tis UK More on this story... Biotechnology Pelage Pharma raises $120 million to fund hair loss treatment research 16 October 2025 Pharmaceutical Veradermics closes $150 million Series C financing 17 October 2025 Biotechnology Scholar Rock shares suffer on manufacturing site woes 14 October 2025 Companies featured in this story More ones to watch > Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news Today's issue Biot
Pelage Pharmaceuticals | | The Pharmaletter Friday 5 June 2026 About Contact Login VC & Investment M&A AI Podcasts News Pharmaceutical News Biotechnology News Generics News Biosimilars news In Brief Legal Company Pages In The Boardroom Insights Analysis Special Report Interviews Expert View From Our Correspondent One To Watch Companies Digital Pharma Pharma Leaders Regulatory FDA EMA Pricing, Reimbursement and Access Regulation Government Affairs Trump Administration Therapy Areas Dermatologicals Oncology Neurological Rare Diseases Hematology Cardio Vascular Diabetes Cell And Gene Ther … n into a cure for balding 14 November 2025 Pelage Pharma raises $120 million to fund hair loss treatment research 16 October 2025 Pelage pockets $16.75 million for hair loss mission 27 February 2024 More Pelage Pharmaceuticals news > Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news Today's issue Pharmaceutical ASCO 2026: Survival gains, bispecifics and ADC scrutiny shape oncology agenda 4 June 2026 Biosimilars Tev
AI Summit - BIO International Convention 2026 Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW Start your engines! BIO 2026 is June 22-25 at the San Diego Convention Center. Program announced! See the 130+ sessions in 18 focus areas. Generate Your Personal Event Schedule in Seconds! GENERATE NOW June 22-25 | San Diego Event Info Event Overview About BIO International Convention Future dates Attendee Policies Schedule at a Glance FAQs In … ific Progress AI Implementation Biomanufacturing Academia Company Presentations Apply for a Company Presentation 2026 Presenting Companies Curated Programs AI Summit BIO Storytelling Stage BioProcess Theater Global Innovation Hubs Professional Development Courses Start-Up Stadium Student Program BIO Partnering™ BIO Partnering™ at BIO 2026 BIO Partnering™ Overview Pre-Event Webinars Partnering Resources LOG IN TO BIO PARTNERING Participating Companies All Partnering Companies … g™ Spotlights Amgen Genentech Boehringer Ingelheim Lilly Sanofi Academic Campus Apply for Academic Campus Exhibition Exhibition Directory Exhibitor List Exhibition Map Networking Networking at BIO Receptions Exhibitor In-Booth Events Other Events Social Spotlight Events Affiliate Events Application List your event Special Experiences 5K and 1 Mile Course Match Day Lounge Travel Hotel Reservations Book Your Hotel Interactive Hotel Map Hotels by Amenity Hotel Guidelines Transpo … , high-fidelity genomic data, represents a major shift in how we understand and apply biology. Large-scale AI models trained on genomic and transcriptomic data enable researchers to predict biological behavior before running an experiment - accelerating discovery, improving clinical decision-making, and enabling more efficient d ... 3:00 PM – 4:00 PM AI Summit Session AI and Digital Health 28ABCDE Twitter LinkedIn Email Share Data Hunger, Enterprise Risks: Biomedical Data and
Latest News about Immunis' Investigational Secretome Treatment & Clinical Trial Home About Us Mission Technology Leadership Resources About secretome biologics About IMM01-STEM About sarcopenia Interested in a clinical trial? Pipeline STEM-MYO Program Phase 1/2a Clinical Trial STEM-META Program Phase 2 Clinical Trial News Awards Media Press Releases Contact ✕ Recent News Mar 5, 2026 Immunis Licenses Treatment Candidate for Dyskinesia Associated with Parkinson’s Disease Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exc … Honored with the National Academy of Medicine’s 2025 Healthy Longevity Catalyst Award Immunis, Inc., a clinical-stage biotech pioneering multi-active stem cell-derived biologics for age and disease-related immune dysregulation, is thrilled to reveal that it is a recipient of the prestigious National Academy of Medicine's (NAM) Healthy Longevity Catalyst Award for 2025. This globally recognized award honors bold biomedical innovations that show promise in dramatically improvin … h & Life Sciences Companies for 2025” by The Healthcare Technology Report. This award is highly regarded by corporate executives, institutional investors, and industry leaders, cementing Immunis’ reputation as a groundbreaking force in biomedical innovation. May 12, 2025 Immunis Named a Semifinalist in the $101 Million XPRIZE Healthspan Competition Immunis, Inc., a clinical-stage biotech developing multi-active biologics for age and disease-related immune dysregulation, was s … ase-related immune dysregulation, was selected as one of the Top 40 Milestone 1 award winners for the $101 Million XPRIZE Healthspan Competition. Award-winning teams will each receive $250,000 to help support them through the next phase of the competition and all semi-finalists will be recognized during the XPRIZE Healthspan Award Ceremony and Investor Summit in NYC (May 12-14). Mar 4, 2025 Immunis Treats its First Patients for Sarcopenic Obesity Immunis, Inc., a clinical-sta … ed immune dysregulation, has closed a $25 million Series A-1 financing round to fund two Phase 2 clinical trials. Follow-on investments from all major existing investors, notably, Remiges Ventures, Continuum Health Ventures and BOLD Capital Partners were joined by new investments from LifeSpan Vision Ventures and JLS Fund among others, including
Machine Learning for Health (ML4H): Advancing Healthcare for All NeurIPS 2020 CSP Test --> Skip to yearly menu bar Skip to main content Main Navigation NeurIPS Help/FAQ Contact NeurIPS Create Profile Code of Ethics Code of Conduct Journal To Conference Track Diversity & Inclusion Proceedings Future Meetings Press Exhibitor Information Privacy Policy Downloads My Stuff Login Select Year: (2020) 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Earlier Conferences Getting Started Schedule Featured Invited Talks Outstanding Paper Awards A … Beaulieu-Jones ⋅ Danielle Belgrave ⋅ Tristan Naumann Project Page Abstract The application of machine learning to healthcare is often characterised by the development of cutting-edge technology aiming to improve patient outcomes. By developing sophisticated models on high-quality datasets we hope to better diagnose, forecast, and otherwise characterise the health of individuals. At the same time, when we build tools which aim to assist highly-specialised caregivers, we limit
NeurIPS 2025 - Microsoft Research 주 콘텐츠로 건너뛰기 Research Publications Code & data People Microsoft Research blog Artificial intelligence Audio & acoustics Computer vision Graphics & multimedia Human-computer interaction Human language technologies Search & information retrieval Data platforms and analytics Hardware & devices Programming languages & software engineering Quantum computing Security, privacy & cryptography Systems & networking Algorithms Mathematics Ecology & environment Economics Medical, health & genomics Social sciences Technology for emerg
ML4H Home About History Past Events Organizing Committee Governing Board Sponsor Submit Call for Papers Call for Demonstrations Mentorship Programs Attend Schedule Speakers Research Roundtables Plan Your Visit Resources Writing Guidelines Reviewing Guidelines Community Guidelines Code of Conduct Review Policy Publication Ethic FAQs Job Board Home About History Past Events Organizing Committee Governing Board Sponsor Submit Call for Papers Call for Demonstrations Mentorship Programs Attend Schedule Speakers Research Roundtables Plan Your Visit Resources Writing Guidelines Reviewing Guidelines C … e Westin San Diego Gaslamp Aug 1: Submission site opens Sep 8: Paper submission deadline Oct 27: Decisions released Please direct any questions to [email protected] For announcements, follow us on Twitter @symposiumml4h 24 Speakers 2.5k Attendees 80 Awards Schedule Registration Sponsors Diamond Gold Silver Design & Developed by ThemesPride Back to Top
JPM26: Biopharma Projected Positivity in San Francisco. Now It's Time To Execute - BioSpace News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs Companies Hotbeds More Reports Career Advice NextGen: Top Startups to Watch 40 Under 40 Best Places to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event SUBSCRIBE Menu SUBSCRIBE Show Search News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy C … laces to Work Employer Resources Advertise Advertise Talent Solutions Post Jobs Submit a Press Release Submit an Event Search Query Submit Search News Business JPM26: Biopharma Projected Positivity in San Francisco. Now It’s Time To Execute January 27, 2026 | 6 min read | Annalee Armstrong , Dan Samorodnitsky Twitter LinkedIn Facebook Email Print The Westin St. Francis in San Francisco, home of the J.P. Morgan Healthcare Conference Anna … g for promising drugs in China. Marc Appel, managing partner at venture capital fund Pacific Bridge NY, added a rarer point-of-view at a panel event on the sidelines of JPM26: that the increasing rush of pharma companies to China for assets and deals was, in fact, a mutually beneficial arrangement for both the U.S. and China. And that even though there’s been discussion of blocking off Chinese entities from the American pharma industry, that hasn’t actually happened. “Althoug … Policy RSS Feeds Advertise Employer Login Post Jobs Talent Solutions Advertise Submit a Press Release Submit an Event © 1985 - 2026 BioSpace.com. All rights reserved. twitter instagram facebook linkedin
Greater Los Angeles Newsletter | May 2024 - Biocom Skip to main content Search Cancel Select Location Choose a location San Diego Greater Los Angeles Bay Area Seattle Sacramento Washington, D.C. Tokyo Enter your location ZIP Code Submit Location Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podcast Episodes About About Us Our Team Board of Directors Careers Contact Our L … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Membership Member Benefits Become a Member Conference & Events Funding & Partnering Group Purchasing Policy & Advocacy Workforce Development International Connections Increase Visibility Community Building Catalyst: Innovators Under 40 Converge: Life Science x Tec … ent Member Benefits Career Hub HR Biotech Group (HRBG) Professional Development Fellowship Programs Affiliated Organizations Biocom Institute Generation STEAM Festival of Science & Engineering Join Member Login Career Hub Venture Hub News & Insights Newsroom News Releases Media Resources In the News Economic Impact Report CEO Updates Newsletters Subscribe Regional Policy & Advocacy Group Purchasing LifeLines Innovations Interviews Insights Involvement Past Podc … t their inaugural Biomedical Science Enrichment Program (BSEP) PitchFest as the fellowship cohort unveiled their groundbreaking ideas to combat health disparities. These innovative solutions were be presented TedX-style directly to NASA members and biomedical professionals, giving them a real-world, high-value experience while showcasing their talent and impactful ingenuity. Advocacy and Public Policy Biocom California Shines a Spotlight on LA’s Westside April’s Sp … ilers in LA, San Bernardino, Riverside and Orange Counties. If passed, it would apply to all new and existing commercial and multifamily units, with mandatory compliance by 2026 for new buildings and 2029 for existing. SCAQMD’s projected costs fall between $49 and $97 million per year, but outside experts show five to ten times higher. Los Angele